DPIIT recognised startup Government of India
Startup India
Matmon Pharmaceuticals Private Limited
Matmon Pharmaceuticals Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.22 Cr
▲ 35% YoY
Net loss · FY 2025
₹16,413
Net margin -0.1%
EBITDA · FY 2025
₹4.73 Lakh
EBITDA margin 1.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
2
GST registered
About Matmon Pharmaceuticals Private Limited
Data last updated:
Matmon Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24299WB2021PTC248327. Its GSTIN is 19AAPCM0082J1Z3 (West Bengal). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Anuj Kaushal and Pramod Kumar Gupta.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 42 Ganesh Chandra Avenue, Kolkata, West Bengal, India – 700013.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.22 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net loss of ₹16,413 (net margin -0.1%) and EBITDA of ₹4.73 Lakh (EBITDA margin 1.5%).
Matmon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0048449).
Company details
CIN U24299WB2021PTC248327
Registration Number 248327
Incorporation Date 27 September 2021
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0048449
Recognitions & Rankings of Matmon Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0048449
Contact details
Matmon Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address42 Ganesh Chandra Avenue, Kolkata, West Bengal, India – 700013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Matmon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Matmon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Matmon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Matmon Pharmaceuticals Private Limited, buy the company report.
Financials of Matmon Pharmaceuticals Private Limited
FY 2025 filings availableMatmon Pharmaceuticals Private Limited reported revenue of ₹3.22 Cr (up 35% YoY) for FY 2025.
Revenue · FY 2025
₹3.22 Cr ▲ 35%
Net loss · FY 2025
₹16,413 margin -0.1%
EBITDA · FY 2025
₹4.73 Lakh margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
EBITDA CAGR growth
1 year
▼ 39%
3 years · compounded
▲ 161%
Revenue rose 35% in the latest year. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹4.73 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹16,413 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.5% | |||
| Net Profit Margin | -0.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Matmon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Matmon Pharmaceuticals Private Limited
Matmon Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Kaushal | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Pramod Kumar Gupta | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Debasmita Kaushal | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Matmon Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Radhika Bio Technologies Private Limited | ₹3.24 Cr (FY 2025) | -49.0% | Agra, Uttar Pradesh, India | |||
| Pulin Pharmaceuticals Private Limited | ₹3.22 Cr (FY 2025) | 4.0% | Jaipur, Rajasthan, India | |||
| Sigmoid Healthcare Private Limited | ₹3.22 Cr (FY 2025) | 4.0% | Jaipur, Rajasthan, India | |||
| Matmon Pharmaceuticals Private Limitedthis company | ₹3.22 Cr (FY 2025) | -₹16,413 | -0.1% | 35.0% | Kolkata, West Bengal, India | |
| Emphasis Pharma Private Limited | ₹3.21 Cr (FY 2025) | 25.0% | Bhopal, Madhya Pradesh, India | |||
| Autiyuq 1 Whole Life Private Limited | ₹3.21 Cr (FY 2025) | -30.0% | Anna Nagar, Chennai-600 040, Tamil Nadu, India |
To see the full peer comparison of Matmon Pharmaceuticals Private Limited, buy the company report.
Auditor
Matmon Pharmaceuticals Private Limited is audited by S K MOHATA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K MOHATA & ASSOCIATES | FY 2023 | 330563E |
Shareholding
The shareholding of Matmon Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Matmon Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Matmon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Matmon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Matmon Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
Active EPFO establishments
1
GST
Matmon Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAPCM0082J1Z3 | West Bengal | Active | 10 Dec 2021 |
| 06AAPCM0082J1ZA | Haryana | Active | 20 Jul 2022 |
To see the full GST registrations and return filing status of Matmon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Matmon Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anuj Kaushal was appointed as Director on 27 Sep 2021.
AGM
Matmon Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Matmon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Appointed
Anuj Kaushal was appointed as Director.
Appointed
Debasmita Kaushal was appointed as Director.
Appointed
Pramod Kumar Gupta was appointed as Director.
Incorporation
27 Sep 2021
Matmon Pharmaceuticals Private Limited was registered on 27 Sep 2021 with Roc Kolkata & aged 5 years 1 month as per MCA records.
Frequently asked questions
Matmon Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 September 2021 (5+ years old) and is registered under CIN U24299WB2021PTC248327.
Matmon Pharmaceuticals has 3 current directors:
- Anuj Kaushal - Director
- Pramod Kumar Gupta - Director
- Debasmita Kaushal - Director
The latest financial statements of Matmon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Matmon Pharmaceuticals is 19AAPCM0082J1Z3, registered in West Bengal. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAPCM0082J1ZA (Haryana).
The CIN (Corporate Identification Number) of Matmon Pharmaceuticals is U24299WB2021PTC248327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Matmon Pharmaceuticals was incorporated on 27 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Matmon Pharmaceuticals by revenue are Radhika Bio Technologies Private Limited, Pulin Pharmaceuticals Private Limited, Sigmoid Healthcare Private Limited, Emphasis Pharma Private Limited, Autiyuq 1 Whole Life Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anuj Kaushal was appointed as Director on 27 Sep 2021. Debasmita Kaushal was appointed as Director on 27 Sep 2021. Pramod Kumar Gupta was appointed as Director on 27 Sep 2021.
Yes, Matmon Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Matmon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0048449).
The registered office of Matmon Pharmaceuticals is at 42 Ganesh Chandra Avenue, Kolkata, West Bengal, India – 700013.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages